Onelax Senna Syrup
NDC Package 17856-1127-2
Package Information
Onelax Senna (senna) syrups is take preferably at bedtime or as directed by a doctor. This formulation utilizes a syrup delivery system. Marketed by Atlantic Biologicals Corp., this product is identified by NDC 17856-1127 and is authorized under FDA application M007.
Identification & Billing
- RxCUI: 702311 - sennosides 8.8 MG in 5 mL Oral Solution
- RxCUI: 702311 - sennosides, USP 1.76 MG/ML Oral Solution
- RxCUI: 702311 - sennosides 8.8 MG per 5 mL Oral Syrup
- RxCUI: 702311 - sennosides, USP 26.4 MG per 15 ML Oral Solution
- RxCUI: 702311 - sennosides, USP 8.8 MG per 5 ML Oral Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 17856 - Atlantic Biologicals Corp.
- 17856-1127 - Onelax Senna
- 17856-1127-2 - 72 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE / 5 mL in 1 CUP, UNIT-DOSE (17856-1127-6)
- 17856-1127 - Onelax Senna
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (17856-1127). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 17856-1127-2 identifies a specific commercial package of 72 cup, unit-dose in 1 box, unit-dose / 5 ml in 1 cup, unit-dose (17856-1127-6) of Onelax Senna, a human over the counter drug labeled by Atlantic Biologicals Corp.. This syrup is formulated for oral use and contains sennosides a and b as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Atlantic Biologicals Corp. on February 06, 2024. The current certification is valid through December 31, 2026.
How is this Atlantic Biologicals Corp. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 17856112702. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.